Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Long-Term Deferred Tax (2025 - 2026)

TransMedics has reported Long-Term Deferred Tax over the past 1 years, most recently at $83.5 million for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax changed N/A year-over-year to $83.5 million; the TTM value through Dec 2025 reached $83.5 million, changed N/A, while the annual FY2025 figure was $83.5 million, N/A changed from the prior year.
  • Long-Term Deferred Tax for Q4 2025 was $83.5 million at TransMedics.
  • Over five years, Long-Term Deferred Tax peaked at $83.5 million in Q4 2025 and troughed at $83.5 million in Q4 2025.